VA-LINEAGE-LOGISTICS
27.10.2021 15:02:16 CEST | Business Wire | Press release
Lineage Logistics, LLC (“Lineage” or the “Company”), the world’s largest and most innovative temperature-controlled industrial REIT and logistics solutions provider, today announced the opening of its newest fully automated facility strategically located near the Port of Virginia’s world-renowned Virginia International Gateway in Portsmouth which offers an integrated network of highways, air, rail, and sea services.
The new state-of-the-art cold storage warehouse joins Lineage’s growing network of over 22 fully automated facilities worldwide. The Company’s growing automation presence comes at a critical time for the cold chain sector as the pandemic accelerated much-needed change to operations and systems within the decades-old cold storage industry. Lineage’s industry-leading automation technology increases storage density, maximizes capacity, provides real-time inventory management, and keeps food safe all while reducing energy consumption.
“As a testament to the power of public-private partnership, we are so pleased to announce the opening of our state-of-the-art facility in Portsmouth,” said Brian Beattie, Senior Vice President of Sale at Lineage Logistics. “Lineage’s innovative technology used in the Portsmouth warehouse will help our customers address rising supply chain demands both nationally and internationally while contributing to the ongoing economic development and job development in the region.”
Portsmouth Economic Development alongside the Virginia Economic Development Partnership, the Portsmouth Ports & Industrial Commission, and the Virginia Port Authority worked to secure the project for Lineage, which in the end resulted in the $84 million investment, produced over 80 high-paying jobs with a Portsmouth-first plan, and remediated a former chemical plant site that was previously vacant – all of which have benefited and will continue to support the city’s economic expansion.
“Portsmouth is thrilled to welcome Lineage Logistics to our business community,” said Shannon E. Glover, Mayor of Portsmouth. “Lineage has already become a wonderful community partner with its participation in our Portsmouth@Work programs, its commitment to supporting Portsmouth residents and businesses, and in the redevelopment of a key brownfield site. We look forward to Lineage continuing to grow in Portsmouth.”
The 167,264 square-foot facility, which is adjacent to the Virginia International Gateway, provides Lineage with access to key markets and will serve as a critical hub to connect people with food around the world. The facility will also aid in strengthening the supply chain and logistics infrastructure in Portsmouth as well as address the growing demand for cold storage in the region. The facility includes 26,000 pallet positions and blast freezing capabilities.
“This new cold storage facility is an important regional asset that is going to create jobs, provide greater flexibility to movers of cold cargo and help increase volumes of cold cargo moving across The Port of Virginia,” said Stephen A. Edwards, CEO and Executive Director of the Virginia Port Authority. “When we expanded and optimized Virginia International Gateway [just two years ago] we added a significant amount of capacity to handle cold cargo. Lineage’s new facility, which isn’t far from the gates at VIG, is going to help directly support our investment and make the port a destination for movers of cold cargo. We look forward to working with Lineage Logistics and helping to maximize its investment here.”
At 10:30 AM EST today, leaders from Lineage Logistics will be joined by Portsmouth community leaders and business partners, including Senator Louise Lucas, Secretary Brian Ball and Portsmouth Mayor Shannon Glover, to celebrate the hard work of the teams who transformed the facility from concept to reality. The event will include a ribbon-cutting ceremony, followed by group tours of the facility.
About Lineage Logistics
Lineage Logistics is the world’s largest temperature-controlled industrial REIT and logistics solutions provider. It has a global network of over 400 strategically located facilities totaling over 2 billion cubic feet of capacity which spans 15 countries across North America, Europe and Asia-Pacific. Lineage’s industry-leading expertise in end-to-end logistical solutions, its unrivaled real estate network, and development and deployment of innovative technology help increase distribution efficiency, advance sustainability, minimize supply chain waste, and most importantly, as a Visionary Partner of Feeding America, help feed the world. In recognition of the company’s leading innovations and sustainability initiatives, Lineage was listed as No. 17 in the 2021 CNBC Disruptor 50 list, the No 1. Data Science company, and 23rd overall, on Fast Company’s 2019 list of The World’s Most Innovative Companies, in addition to being included on Fortune’s Change The World list in 2020.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211027005235/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
